FOTIVDA .89 mg/1
Tivozanib · CAPSULE · AVEO Pharmaceuticals, Inc.
Fotivda (tivozanib) is an oral capsule taken by mouth that is used to treat advanced renal cell carcinoma, a type of kidney cancer. It works by blocking certain proteins that help cancer cells grow and spread.
Key Facts
- Brand Name
- FOTIVDA
- Generic Name
- Tivozanib
- NDC Code (Product)
45629-089- Manufacturer
- AVEO Pharmaceuticals, Inc.
- Strength
- .89 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA212904
- Marketing Start
- 03/10/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is FOTIVDA used for?
Fotivda (tivozanib) is an oral capsule taken by mouth that is used to treat advanced renal cell carcinoma, a type of kidney cancer. It works by blocking certain proteins that help cancer cells grow and spread.
Is FOTIVDA a controlled substance?
FOTIVDA is not classified as a controlled substance by the DEA.
What is the generic name for FOTIVDA?
The generic name for FOTIVDA is Tivozanib. There are no other listed brand versions of Tivozanib.
What is the NDC code for FOTIVDA .89 mg/1?
The NDC (National Drug Code) for FOTIVDA .89 mg/1 is 45629-089, listed by AVEO Pharmaceuticals, Inc..
Other FOTIVDA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)